US Patent Issued to NATIONAL CANCER CENTER, JP BIO A, KOOKMIN UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION on Jan. 20 for "Humanized antibody to digoxigenin and uses thereof" (South Korean Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,881, issued on Jan. 20, was assigned to NATIONAL CANCER CENTER (Goyang-si, South Korea), JP BIO A INC. (Seongnam-si, South Korea) and KOOKMIN UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION (Seoul, South Korea).

"Humanized antibody to digoxigenin and uses thereof" was invented by Yun Hee Kim (Goyang-si, South Korea), Kyun Heo (Seoul, South Korea), In Hoo Kim (Goyang-si, South Korea) and Sun Il Choi (Goyang-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to humanized antibodies having good binding ability to digoxigenin and uses thereof. When an antibody or antigen-binding fragment thereof specifically ...